Vaccine

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
69
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Influenza

Conditions

Influenza

Trial Timeline

Nov 28, 2016 โ†’ Mar 25, 2017

About Vaccine

Vaccine is a phase 3 stage product being developed by Comac Medical for Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT02935192. Target conditions include Influenza.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02935192Phase 3Completed